Quotient Ltd. Daily Stock Analysis

Daily Stock Analysis, QTNT, Quotient Ltd, priceseries

Quotient Ltd. Daily Stock Analysis
Stock Information
Open
1.13
Close
1.20
High
1.21
Low
1.12
Previous Close
1.16
Daily Price Gain
0.04
YTD High
2.61
YTD High Date
Jan 3, 2022
YTD Low
1.12
YTD Low Date
Mar 7, 2022
YTD Price Change
-1.18
YTD Gain
-49.58%
52 Week High
4.53
52 Week High Date
Jun 1, 2021
52 Week Low
1.12
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-2.98
52 Week Gain
-71.29%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 4. 2017
5.06
Jan 12. 2017
5.39
6 Trading Days
6.51%
Link
LONG
Apr 27. 2017
6.56
May 17. 2017
7.14
14 Trading Days
8.89%
Link
LONG
Feb 13. 2018
3.90
Mar 20. 2018
5.76
24 Trading Days
47.77%
Link
LONG
May 2. 2018
4.29
May 16. 2018
4.65
10 Trading Days
8.48%
Link
LONG
Jun 15. 2018
7.14
Jun 27. 2018
7.95
8 Trading Days
11.38%
Link
LONG
Jan 4. 2019
6.30
Mar 5. 2019
10.18
40 Trading Days
61.56%
Link
LONG
Jul 2. 2019
9.29
Jul 25. 2019
10.48
16 Trading Days
12.83%
Link
LONG
Apr 6. 2020
4.62
Apr 7. 2020
4.97
1 Trading Days
7.58%
Link
LONG
Apr 24. 2020
6.51
May 4. 2020
7.95
6 Trading Days
22.08%
Link
LONG
Oct 30. 2020
4.72
Dec 10. 2020
6.79
28 Trading Days
43.76%
Link
LONG
Oct 1. 2021
2.72
Oct 11. 2021
2.88
6 Trading Days
5.91%
Link
LONG
Dec 1. 2021
2.31
Dec 3. 2021
2.45
2 Trading Days
6.06%
Link
LONG
Dec 16. 2021
2.12
Jan 3. 2022
2.40
11 Trading Days
13.35%
Link
Company Information
Stock Symbol
QTNT
Exchange
NasdaqGM
Company URL
http://www.quotientbd.com
Company Phone
41274832286
CEO
Paul Cowan
Headquarters
-
Business Address
28 ESPLANADE, SAINT HELIER, JERSEY JE2 3QA
Sector
Equity
Industry Category
Drugs
Industry Group
Diagnostic Substances
CIK
0001596946
About

Quotient Ltd. operates as a diagnostics company. It provides immunohematology products to hospitals and blood banks. The company develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. Quotient was founded on January 28, 2012 and is headquartered in Penicuik, the United Kingdom.

Description

Quotient Limited, a diagnostics company, develops, manufactures, and commercializes blood transfusion diagnostic products worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. It also develops, manufactures, and commercializes conventional reagent products for blood grouping, including antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company sells its products to donor collection agencies, hospitals, independent testing laboratories, blood banking operations, and other diagnostic companies, as well as to original equipment manufacturers. Quotient Limited was founded in 2007 and is based in Penicuik, the United Kingdom.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading